Skip to content
Screener

SIGA Technologies SIGA Oral TPOXX — Number Of Courses To Be Delivered

Similar metrics at other companies

Delek US Holdings logo
DKOil and gas, quantity to be delivered
$1.2M
Delek US Holdings logo
DKOil and gas, quantity to be delivered
$1.2M
Northern Oil and Gas logo
NOGNumber of revenue sources
20.0%
DigitalBridge Group logo
DBRGCost Reimbursements — Number of hours to be reimburse
1000.0%
Restoration Hardware logo
RHBE — Number Of Stores
10.0%
Perrigo Company logo
PRGOOral Care — Revenue
$88.6M-5.4%

Other financials

Income statement

See full
Revenue$41.0M-49.5%
Gross profit$23.4M-57.8%
Operating income$13.9M-69.6%
Net income$12.5M-64.9%
EPS (diluted)$0.17-65.3%

Balance sheet

See full
Cash & equivalents$117.6M-35.6%
Total debt$439.4K-58.8%
Total equity$165.3M-21.0%
Total assets$175.7M-25.3%

Cash flow

See full
Operating cash flow$15.2M-75.9%
CapEx--100%
Free cash flow$15.2M-75.9%

Valuation

See full
Market cap$225.93M-56.5%
Enterprise value$108.79M-67.9%
P/E5.9×+2.2×
P/S4.2×+1.3×

Profitability

See full
Gross margin54.4%-22.6pp
Operating margin52.4%-7.8pp
Net margin43.2%-6.1pp
FCF margin66.2%

Returns & leverage

See full
Return on equity39.9%-18.5pp
Debt / equity0.0×
Current ratio21.7×+11.6×

Where this comes from

Reported directly by SIGA Technologies in its filing.

Tagged under the XBRL concept siga:NumberOfCoursesToBeDelivered.

The source filing: SIGA Technologies’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 4:46 PM EDT
Fiscal quarter
Q4 FY2026
Calendar quarter
Q4 2026
Accession
0001437749-26-026314

The options that have been exercised as of June 30, 2026, provide for payments up to approximately $545.2 million. As of June 30, 2026, there are exercised options for the following activities: payments up to $450.2 million for the manufacture and delivery of up to 1.5 million courses of oral TPOXX®; payments up to $76.8 million for the manufacture of courses of IV FDP; payments of up to approximately $3.6 million to fund post-marketing activities for IV TPOXX®; and payments of up to $14.6 million for funding of post-marketing activities for oral TPOXX®. As of June 30, 2026, a cumulative total of $450.2 million of oral TPOXX® has been delivered to the Strategic Stockpile and accepted; a cumulative total of $76.8 million of IV FDP has been delivered to the Strategic Stockpile and accepted (IV BDS that had been set aside and recorded as deferred revenue was recognized as revenue when the IV FDP, containing IV BDS, was delivered); and the Company has been cumulatively reimbursed $13.0 million in connection with post-marketing activities for oral and IV TPOXX®.

Item 1 - Condensed Consolidated Financial Statements

FAQ

What is SIGA Technologies's oral TPOXX — number of courses to be delivered?
SIGA Technologies (SIGA) reported oral TPOXX — number of courses to be delivered of 1.5M in Q2 2026.
How has SIGA Technologies's oral TPOXX — number of courses to be delivered changed year-over-year?
SIGA Technologies's oral TPOXX — number of courses to be delivered decreased by 0.0% year-over-year, from 1.5M to 1.5M.
What does oral TPOXX — number of courses to be delivered mean?
Quantifies the total volume of product units or treatment courses currently obligated for future delivery under existing customer contracts. This metric is a critical operational indicator of the company's backlog and production requirements. It helps investors assess future revenue potential and the operational capacity needed to meet contractual obligations.

Ask your AI about SIGA Technologies's oral tpoxx — number of courses to be delivered.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude